Skip to main content

Advertisement

Fig. 2 | BMC Infectious Diseases

Fig. 2

From: Whole-genome sequences of multidrug-resistant Escherichia coli in South-Kivu Province, Democratic Republic of Congo: characterization of phylogenomic changes, virulence and resistance genes

Fig. 2

Heatmap of antimicrobial susceptibility profiles of DRC ESBL-producing ExPEC isolates. White, grey and black boxes: susceptible, intermediate and resistant to the corresponding antimicrobial drug. All DRC ESBL-producing ExPEC isolates retained susceptibility to imipenem, while displaying resistance to at least three of the following antimicrobial families: beta-lactams (including third and fourth generation cephalosporins), quinolones, sulfonamids, tetracycline and chloramphenicol. AKN: amikacin; AMX: amoxicillin; AMC: amoxicillin-clavulanic acid; AMP: ampicillin; CRO: ceftriaxone; CAZ: ceftazidime; CTX: cefotaxime; CEFUR: cefuroxime; CIP: ciprofloxacin; IMP: imipenem; SXT: trimethoprim-sulfamethoxazole; FEP: cefepime; CHL: chloramphenicol; TET: tetracycline, ESBL: Extended Spectrum Beta-Lactamase phenotype

Back to article page